other material
confidence high
sentiment neutral
materiality 0.60
TherapeuticsMD effects 1-for-50 reverse stock split; authorized shares cut to 12M
TherapeuticsMD, Inc.
- Reverse split effective May 6, 2022; every 50 shares become 1 share.
- Authorized shares reduced from 600M to 12M; fractional shares rounded up.
- Trading on split-adjusted basis under TXMD begins May 9, 2022.
- No stockholder approval required under Nevada law.